Get Free Sample link @ https://www.omrglobal.com/request-sample/european-prostate-cancer-diagnostic-therapeutic-market
European prostate cancer diagnostic and therapeutic market has been studied on the basis of diagnostic techniques and therapeutics. By diagnostic technique, the market is segmented into prostate-specific antigen test, digital rectal examination, prostate biopsy, imaging techniques. Prostate biopsy is expected to hold a major market share during the forecast period. By therapeutics, the market is segmented into hormonal therapy, chemotherapy, immunotherapy, radiation therapy, targeted therapy, surgery. During the forecast period, chemotherapy is expected to have a major market share in the region. Geographically, the market is divided into Germany, France, UK, Spain, Italy and the Rest of Europe. France and Germany are expected to have a major market share during the forecast period. Around 65,000 new cases in France whereas in Germany around 63,000 new cases of prostate cancer were registered in 2018.
A full report of European Prostate Cancer Diagnostic and Therapeutic Market available @ https://www.omrglobal.com/industry-reports/european-prostate-cancer-diagnostic-therapeutic-market
• Market Coverage
• Market number available for – 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Source, By Product Type, By Applications
• Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
European Prostate Cancer Market by Diagnostic Techniques
o Prostate-Specific Antigen Test (PSA)
o Digital Rectal Examination
o Prostate Biopsy
o Imaging Techniques
European Prostate Cancer Market by Therapeutics
o Hormonal Therapy
o Chemotherapy
o Immunotherapy
o Radiation Therapy
o Targeted Therapy
o Surgery
Regional Analysis
o Germany
o UK
o France
o Spain
o Italy
o Rest of Europe
Company Profiles
o Abbott Laboratories
o AbbVie Products, LLC
o Amgen Inc.
o AstraZeneca PLC
o Bavarian Nordic A/S
o Bayer AG
o Bristol-Myers Squibb Co.
o Ferring Pharmaceuticals Inc.
o GlaxoSmithKline PLC
o Ipsen Group
o Johnson & Johnson
o MDNA Life SCIENCES, Inc.
o Pfizer Inc.
o Siemens Healthcare AG
The Report Covers
• Comprehensive research methodology of the European Prostate Cancer Market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the European Prostate Cancer Market.
• Insights about market determinants which are stimulating the European Prostate Cancer Market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-prostate-cancer-diagnostic-therapeutic-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404